Emanuela Palmerini is a medical oncologist, serving at the Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies Unit at the IRCCS Istituto Ortopedico Rizzoli, in Bologna, Italy, since 2005. Her clinical interests are bone and soft tissue tumours. She is responsible for the phase I-III clinical trials in sarcomas. She collaborates with the Research Laboratories at the IRCCS Istituto Ortopedico Rizzoli, pioneering new treatments for these rare tumours. Also, she leads research projects at the Cell Therapy Laboratory and the Hemopathology Laboratory at the Institute of Haematology Seragnoli in Bologna, studying the role of tumor microenvironment and immunotherapy in sarcomas. She has been recognized several awards for sarcoma research and research grants.
In June 2021 she was appointed the National Academic Qualification as Full Professor – Hematology, Oncology and Rheumatology (06/D3). She is member of several scientific societies. She is in the board of Director at European Musculo-Skeletal Oncology Society (EMSOS), member of the Euro-Ewing Consortium Radiation Oncology Working Group, and co-chair of the European consortium FOSTER (Fight OSteosaroma Throught European Research). She has authored or co-authored more than 130 publications in indexed journals, 7 book chapters and 3 musculoskeletal tumors atlas (H-index 37).
